Four years after its initial EU market authorisation, NICE recommended Celgene’s Revlimid® as a first-line treatment in...
I have worked across a wide range of therapeutic areas including Oncology, Immunology and CNS. I have been involved in the development and facilitation of programmes of work focusing on effective strategic planning and launch readiness. My diverse skill-set and deep understanding of market needs have successfully supported clients to develop and enhance their commercial and market access strategies.
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at email@example.com